Skip to main content
Premium Trial:

Request an Annual Quote

Genetic Technologies Licenses IP to Conexio Genomics

NEW YORK (GenomeWeb News) – Genetic Technologies announced today it is licensing patents related to its non-coding DNA technology to Conexio Genomics.

Financial and other terms of the non-exclusive deal were not disclosed.

Based in Fremantle, Western Australia, Conexio develop genetic sequencing and mutation detection products and provides services in those areas.

The patents covering GTG's technology have been at the center of numerous lawsuits the Australian molecular diagnostic test development firm has filed in recent years. Last week, it announced it is suing Reproductive Genetics Institute alleging infringement of a patent covering the technology.

GTG has also previously sued other firms including Beckman Coulter, Gen-Probe, which is now part of Hologic, and Agilent Technologies. It has settled its legal disputes with other companies surrounding the technology, including GeneSeek, Navigenics, Hologic, and Eurofins.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.